JOHN HOPE FRANKLIN CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1838-01-01

Employees: 5K

Market Cap: -

Website: http://www.duke.edu

Clinical Trials

Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia

Phase 1

Terminated

Conditions: Sarcoma, Soft Tissue
Osteosarcoma
Neoplasms, Connective and Soft Tissue

First Posted Date: 2011-12-14

Last Posted Date: 2014-04-02

Lead Sponsor: Duke University

Target Recruit Count: 1

Registration Number: NCT01491594

Locations: 🇺🇸
Duke Cancer Center, Durham, North Carolina, United States

Treatment of Vasopressor-induced Ischemia With Botulinum Toxin A

Not Applicable

Terminated

Conditions: Ischemia
Vasopressor

Interventions: Drug: Injection of botulinum toxin A

First Posted Date: 2011-12-01

Last Posted Date: 2015-03-02

Lead Sponsor: Duke University

Target Recruit Count: 2

Registration Number: NCT01483209

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Pre and or Post Operative Blood Pressure Control With Clevidipine (Cleviprexm Medicines Company) in Aortic Aneurysm / Dissection

Not Applicable

Withdrawn

Conditions: Aorta Aneurysm
Dissection of Aorta

First Posted Date: 2011-11-29

Last Posted Date: 2013-02-11

Lead Sponsor: Duke University

Registration Number: NCT01480531

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)

Not Applicable

Completed

Conditions: Obstetric Labor Complications
Post-partum Hemorrhage
Sepsis
Pre-eclampsia
Neonatal Mortality

First Posted Date: 2011-11-29

Last Posted Date: 2015-12-16

Lead Sponsor: Duke University

Target Recruit Count: 14990

Registration Number: NCT01480544

Locations: 🇮🇳
Imatchine, Bangalore, Karnataka, India

New Therapy for Patients With Severe Tinnitus

Not Applicable

Completed

Conditions: Tinnitus

Interventions: Other: Sound Based and Educational Therapies
Other: Integrative Medicine Therapies and Sound Based Education Therapies

First Posted Date: 2011-11-28

Last Posted Date: 2019-04-09

Lead Sponsor: Duke University

Target Recruit Count: 40

Registration Number: NCT01480193

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Mila Blooms Intervention Study

Not Applicable

Completed

Conditions: Childhood Cancer

Interventions: Behavioral: Mila Blooms

First Posted Date: 2011-11-17

Last Posted Date: 2014-10-24

Lead Sponsor: Duke University

Target Recruit Count: 21

Registration Number: NCT01473342

Locations: 🇺🇸
Duke University Medical Center, Dept. of Community and Family Medicine, Durham, North Carolina, United States

Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)

Phase 4

Completed

Conditions: Complication of Transplanted Lung

Interventions: Drug: Aztreonam Lysine for Inhalation (AZLI)
Procedure: Status Post Lung Transplant

First Posted Date: 2011-11-10

Last Posted Date: 2016-01-29

Lead Sponsor: Duke University

Target Recruit Count: 30

Registration Number: NCT01469364

Locations: 🇺🇸
David Geffen School of Medicine at UCLA, Los Angeles, California, United States
🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Obesity in HIV After Antiretroviral Therapy

Completed

Conditions: Obesity
AIDS
HIV

Interventions: Drug: antiretroviral therapy

First Posted Date: 2011-10-28

Last Posted Date: 2015-10-14

Lead Sponsor: Duke University

Target Recruit Count: 200

Registration Number: NCT01461876

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

Vasospasm in Pediatric Traumatic Brain Injury

Completed

Conditions: Brain Injury

First Posted Date: 2011-10-28

Last Posted Date: 2015-02-02

Lead Sponsor: Duke University

Target Recruit Count: 6

Registration Number: NCT01461902

Locations: 🇺🇸
Duke University medical Center, Durham, North Carolina, United States

Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)

Phase 4

Completed

Conditions: Urinary Tract Infection

Interventions: Drug: Nitrofurantoin
Drug: Placebo

First Posted Date: 2011-10-12

Last Posted Date: 2017-02-13

Lead Sponsor: Duke University

Target Recruit Count: 163

Registration Number: NCT01450800

Locations: 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy